All news is rigorously fact-checked and reviewed by leading blockchain experts and seasoned industry insiders.
- Ondo Finance integrates with Injective, introducing the USDY token to enhance capital efficiency in Injective dApps.
- Injective accelerates tokenized asset adoption with the world’s first RWA module supporting FX, commodities, and more.
Ondo Finance has officially integrated with Injective, marking a significant step forward in the spread of tokenized financial instruments inside the blockchain ecosystem. This partnership offers USDY, a novel tokenized treasury instrument, to the Injective ecosystem.
1/ Starting today, @OndoFinance is officially integrated with Injective, bringing an innovative tokenized treasury instrument, USDY, into the Injective ecosystem while also enabling new institutional and RWA use cases for $INJ pic.twitter.com/X2Q30I1Jd9
— Injective 🥷 (@injective) July 22, 2024
A Broader Vision: Enabling New Institutional and RWA Use Cases for INJ Token
This step is more than just the integration of a new token; it represents a larger vision of enabling new institutional and real-world asset (RWA) use cases for the INJ token. USDY can now be used in a variety of Injective-based applications, thereby increasing capital efficiency.
It also incorporates embedded tokenized treasury products within Injective decentralized applications (dApps), such as decentralized exchanges and money market platforms.
This collaboration with Ondo exemplifies Injective’s continued attempts to bring traditional finance onto the blockchain. Injective has been at the vanguard of asset tokenization, and the introduction of USDY exemplifies this objective.
The platform’s commitment to promoting the adoption of tokenized assets is evident in the world’s first RWA module, which currently enables on-chain services like foreign exchange (FX), commodities, and more.
CNF previously reported that Injective had introduced AINJ, the 21Shares-released Injective Staking Exchange Traded Product (ETP). This platform promises to connect traditional finance and decentralized markets by offering exposure to INJ as well as staking rewards.
This program is part of Injective’s larger aim to combine traditional financial products with blockchain technology, resulting in a seamless financial environment.
As of this writing, the INJ token is trading around $25.36, down 5.36% over the last 24 hours. This price change appears to be a correction following a bullish trend over the last month, during which INJ has increased by more than 19%.
Despite the recent decline, the overall prognosis remains favorable due to the significant advancements in the Injective ecosystem.
Furthermore, our prior report showed that the Injective burn auction increased by 124% in the last three months, indicating that the platform’s activity and interest are expanding. Injective has also integrated PYUSD, making it one of the first Layer-1 platforms to do so.
These advancements solidify Injective’s position as a prominent player in the blockchain field, with the blockchain constantly innovating and expanding its solutions to meet the changing needs of its users.
